Pricing Log in Create free account

Cadrenal Therapeutics, Inc. (CVKD) vs NuCana PLC Sponsored ADR (NCNA)

Cadrenal Therapeutics, Inc. and NuCana PLC Sponsored ADR are both Biotechnology companies. NuCana PLC Sponsored ADR is the larger, with a market value of $4.0M against $3.6M — 1.1× the size. Across the 9 metrics below, NuCana PLC Sponsored ADR leads on 6 and Cadrenal Therapeutics, Inc. on 3.

Valuation

Metric CVKD NCNA Biotechnology median
P/E n/m n/m 10.60
P/S n/m n/m 9.40
P/B 0.74 0.14 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 1.24 0.66
EV/Sales n/m n/m 9.02
Earnings yield (471.15%) (12,777.07%) (32.88%)
Free cash flow yield (335.44%) (179.93%) (23.13%)

Profitability

Metric CVKD NCNA Biotechnology median
Gross margin 0.00% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (275.16%) (68.70%) (51.96%)
Return on assets (199.59%) (45.24%) (46.06%)
Return on invested capital (427.54%) (1,130.23%) 0.00%

Growth

Metric CVKD NCNA Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 23.94% 98.95% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric CVKD NCNA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.73 4.73 4.97
Net debt to EBITDA 0.30 1.23 1.01

Dividend

Metric CVKD NCNA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CVKD NCNA Biotechnology median
Market cap 3.57m 4.03m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack